Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Recruiting1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT05507411Phase 2Recruiting
Watch and Wait for NeoAdjuvant Concurrent Radiochemotherapy Combined With Camrelizumab in Patients With Resectable ESCC
Esophageal Squamous Cell Carcinoma
PrincipalinvestigatorStart date: 2022-08-03

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Zhejiang Cancer Hospital

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Hui Liu, Professor

Sun Yat-sen University

Moderately Similar
6 trials

Shared therapeutic areas:

Esophageal Squamous Cell Carcinoma
Similarity Score30%

Hui Liu, Ph.D

Sun Yat-sen University

Moderately Similar
6 trials

Shared therapeutic areas:

Esophageal Squamous Cell Carcinoma
Similarity Score30%

guibin Qiao, MD

Guangdong Provincial People's Hospital

Moderately Similar
5 trials

Shared therapeutic areas:

Esophageal Squamous Cell Carcinoma
Similarity Score30%

Christian Abnet, Ph.D.

National Cancer Institute (NCI)

Moderately Similar
6 trials

Shared therapeutic areas:

Esophageal Squamous Cell Carcinoma
Similarity Score30%

Tsang-Wu Liu

Taiwan Cooperative Oncology Group, NHRI

Moderately Similar
5 trials

Shared therapeutic areas:

Esophageal Squamous Cell Carcinoma
Similarity Score30%

Gert J Meijer, PhD

UMC Utrecht

Moderately Similar
2 trials

Shared therapeutic areas:

Esophageal Squamous Cell Carcinoma
Similarity Score30%

Jian Liu (jianliu@nankai.edu.cn), PhD

Nankai University

Moderately Similar
4 trials

Shared therapeutic areas:

Esophageal Squamous Cell Carcinoma
Similarity Score30%

Xiuli Zuo, MD,PhD

Qilu Hospital of Shandong University

Moderately Similar
26 trials

Shared therapeutic areas:

Esophageal Squamous Cell Carcinoma
Similarity Score30%

Vincent Chung, MD

City of Hope Medical Center

Moderately Similar
6 trials

Shared therapeutic areas:

Esophageal Squamous Cell Carcinoma
Similarity Score30%

Josh Neman, PhD

NeOnc Technologies Holdings, Inc.

Moderately Similar
3 trials

Shared therapeutic areas:

Esophageal Squamous Cell Carcinoma
Similarity Score30%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT05507411Phase 2PrincipalInvestigator

Watch and Wait for NeoAdjuvant Concurrent Radiochemotherapy Combined With Camrelizumab in Patients With Resectable ESCC

Esophageal Squamous Cell Carcinoma
Recruiting

All 1 trials loaded